PMID: 9534831Apr 16, 1998Paper

Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT

The British Journal of Psychiatry : the Journal of Mental Science
B ShapiraB Lerer

Abstract

We compared the antidepressant and cognitive effects of up to eight sessions of bilateral, brief pulse electroconvulsive therapy (ECT) administered twice (ECT x 2) or three times weekly (ECT x 3), to confirm that ECT x 3 acts more rapidly although the two schedules are equivalent in antidepressant outcome, and to establish whether ECT x 3 is indeed associated with more severe memory impairment. Patients with major depression, endogenous subtype were randomly assigned to ECT x 3 or ECT x 2 plus one simulated ECT per week, both up to a maximum of eight real ECT. Depression was evaluated by the Hamilton Depression Scale the day after each treatment and cognitive function by a test battery administered before and after the ECT series and at one month follow-up. Assessed categorically or parametrically, there was no significant difference in antidepressant outcome between the two schedules. Rate of response was significantly more rapid with ECT x 3 but was associated with more severe memory impairment. Twice weekly administration is an optimum schedule for bilateral ECT unless clinical indications require the more rapid antidepressant effect of three times weekly treatment.

References

Jan 1, 1978·Journal of Clinical Psychology·B Jackson
Jan 1, 1976·Neuropsychologia·A L Thompson, J F Marsh
Nov 1, 1976·Acta Psychiatrica Scandinavica·L S StrömgrenP Fromholt
Oct 1, 1975·Acta Psychiatrica Scandinavica·L S Strömgren
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Aug 1, 1989·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·H C Schwartz
Jan 1, 1986·Annals of the New York Academy of Sciences·R D WeinerL R Squire
May 1, 1987·Psychiatry Research·D A McAllisterA Sattin
Jan 1, 1981·Archives of General Psychiatry·L R SquireP L Miller
Apr 1, 1995·The American Journal of Psychiatry·B LererJ E Schwartz
Apr 1, 1993·Journal of Affective Disorders·B N GangadharA K Reddy

❮ Previous
Next ❯

Citations

Jun 1, 2007·L'Encéphale·S Mouchet-Mages
Jun 18, 2003·Bulletin of the Menninger Clinic·Keith G Rasmussen
Oct 2, 2001·Journal of Affective Disorders·H BrodatyC Mason
Oct 24, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·José Manuel Bertolín-GuillénMaría Eugenia Hernández-de-Pablo
Jan 28, 2004·Biological Psychiatry·Joan PrudicHarold A Sackeim
Apr 14, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Iannis M ZervasCostantin R Soldatos
Mar 14, 2001·Journal of Affective Disorders·M Fink
Jun 27, 2002·Journal of Geriatric Psychiatry and Neurology·Ilkka KujalaSvein Ivar Bekkelund
Nov 29, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Verònica GálvezColleen K Loo
Aug 30, 2001·Molecular Psychiatry·B Lerer, B Shapira
Apr 23, 2005·The Cochrane Database of Systematic Reviews·P Tharyan, C E Adams
Jun 22, 2010·The Journal of ECT·Bangalore N Gangadhar, Jagadisha Thirthalli
Sep 2, 2010·The Journal of ECT·Kenneth TrevinoMustafa M Husain
Apr 2, 2008·The Journal of ECT·Anna IngramIsaac Schweitzer
May 5, 2018·The Journal of ECT·Michelle L MillerDouglas M Whiteside
Jan 22, 2010·CNS Drugs·Richard C SheltonSara A Corya
Jan 19, 2010·British Journal of Nursing : BJN·Adam Kavanagh, Declan M McLoughlin
Aug 13, 2002·Journal of Clinical Psychopharmacology·Chester Pearlman
Jun 27, 2000·The Journal of ECT·H A Sackeim
Jul 3, 2020·Indian Journal of Psychological Medicine·Jagadisha ThirthalliGirish Kunigiri
Apr 25, 2006·The Journal of ECT·Worrawat Chanpattana, Chittaranjan Andrade
Sep 25, 1999·The Medical Journal of Australia·C WijeratneR W Lyndon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.